
Awards and honours (Issue 100)
EMBLetc The work and excellence of EMBL researchers have been recognised with multiple awards and honours during the past six months. Here are some of the awardees.
2023
EMBLetc The work and excellence of EMBL researchers have been recognised with multiple awards and honours during the past six months. Here are some of the awardees.
2023
EMBLetc Scientists at EMBL Rome are developing new paradigms to study the impact of diverse environmental factors on reproduction in mammals and disease risk in their progeny.
2023
Lab Matters EMBL Rome group leader Jamie Hackett receives EUR 2 million for the ModLogic project, aimed at understanding how chromatin modifications impact gene activity.
2023
lab-matters
Science Recent studies from the Hackett group at EMBL Rome have revealed new insights on the mechanism regulating transmission of non-genetic information during embryonic development, and inspired a scientific illustration
2022
science
Science A study conducted by the Hackett group at EMBL Rome has identified key factors controlling the complex system of gene regulation during early embryo development, shedding new light on the mechanisms behind these events and on their evolutionary implications. Their findings are published in Nature…
2020
science
Science EMBL scientists develop a new molecular tool to prevent SARS-CoV-2 infection in mice. This tool is able to cause targeted epigenetic modifications of specific genes in specific cell populations. They will use it in mice to target airway cells that express the ACE2 protein – the receptor that…
2020
science
Science How embryonic stem cells develop into the germ line
2018
science
Science Meet Monterotondo’s new group leader for epigenetic reprogramming and inheritance, Jamie Hackett
2017
science
Science EMBL scientists detect important function of genetic sequence our ancestors assimilated from a virus
2017
science
No matching posts found
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive